Clinical Sites & Tech Transfer

Monetize Trial Capacity. Commercialize Lab IP.

Hospitals, CROs, research labs, and tech transfer offices: join the IGVP OS to run trials for venture-backed startups and commercialize lab IP globally.

CDSCO Clinical Trial ComplianceFDA Pre-Sub Support Desk80/20 Tech Transfer Framework

Clinical Trial Site & IP Matcher

Cross-Border Desk · Live Sourcing

● Verified Sites
Select Partner Node Region:

AIIMS Cardiology Trial Wing

Matched with 3 Delaware C-Corp medtech ventures

60% Cost Reduction

C-CAMP Licensing Desk

2 provisional patents under licensing review

Active Review

Co-Development Deal Pipeline

First-look access to top Accelerator ventures

Institutional Collaboration

Why Institutional Partners Choose IGVP

Monetize research infrastructure, clinical trial capacity, and university tech transfer IP

Legacy Approach

Traditional Market Friction

● High Risk

Underutilized Trial Capacity & Idle Research IP

Your institution has trial capacity, research infrastructure, or licensable IP sitting underutilized — but no structured channel to reach credible, investment-ready ventures on the other side of the border.

Common Obstacles & Bottlenecks:

Idle Clinical Capacity

Hospital trial wings operating under 50% capacity due to high Western sponsor costs.

Dormant University Patents

High-potential academic IP gathering dust without commercialization channels.

Friction in Cross-Border Contracting

Bureaucratic delay in executing CDSCO/FDA multi-center research agreements.

Slow AccelerationStatus: Bottlenecked
IGVP Enterprise Engine

Structured Operating System

● Verified Solution

Structured Cross-Border Clinical & Licensing Desk

IGVP integrates your institution directly into our Accelerator deal flow — filling trial capacity with pre-funded ventures and licensing institutional IP under standard 80/20 commercial terms.

IGVP System Advantages:

Pre-Funded Sponsor Pipelines

Direct assignment of Delaware C-Corp ventures with pre-allocated trial budgets.

Commercial Tech Transfer

Standardized 80/20 IP licensing frameworks for university research labs.

Standardized CDSCO/FDA Desks

Fast-track legal and ethical board clearance with IGVP template agreements.

10x Execution Speed

Program Deliverables

What You Get as an Institutional Partner

01

Trial Capacity Sourcing

Direct placement of venture-backed startups into your clinical trial wards and patient registries.

02

IP Licensing Desk

Listing lab patents in front of IGVP Accelerator founders and LP syndicates seeking commercial IP.

03

Regulatory Fast-Track

Standardized CDSCO & FDA IRB/Ethics board clearance templates to slash onboarding delays.

04

Co-Development Grants

First-look access to joint research & grant funding programs sponsored by IGVP Bio Fund.

IGVP Community Architecture · Institutional Partners Track

Role-Gated Discord & WhatsApp Communities

Self-segment upon entry into verified channels designed to accelerate co-founder matching, clinical trials, due diligence, and capital deployment.

Institutional Accreditation Check

Verified for verified CROs, hospital leads & Tech Transfer officers

🏥 Institutional Partners Category

Role Verified

Category Channels

Cross-Pollination Engine: Members collide across co-founder matching and deal-flow channels to fuel the Tri-Engine Flywheel.

clinical-trial-matching
Live Community Feed
AR
Dr. Ananya Roy (AIIMS Clinical Desk)🏥 Institutional Lead
03:40 PM

We have opened 20 cardiology trial slots for Q3 at the New Delhi campus. Looking for pre-funded Delaware C-Corp medtech ventures.

Trial Slots Open
MV
Marcus Vance (Founder, BioPulse)🚀 Accelerator Founder
03:55 PM

Dr. Roy! We just closed our $1.5M seed round and have our FDA pre-sub approved. Sending our trial protocol to your desk now.

Auto-Verification Enabled for Approved Members
Institutional Ecosystem Impact

Accelerating Tech Transfer & Clinical Trials

See how academic medical centers, health systems, and tech transfer offices commercialize breakthrough research through IGVP.

"IGVP's institutional desk streamlined our tech-transfer licensing process. 3 of our university patents spun out into funded startups this year."

Dr. Arthur Pendelton

Dr. Arthur Pendelton

VP Research · Stanford Health Innovation

3 PATENTS LICENSED

"Our health system onboarded 4 clinical trial cohorts through IGVP's pre-diligenced founder channel with IRB approvals completed in under 30 days."

Dr. Jonathan Roy

Dr. Jonathan Roy

Director of Clinical Trials · Mass General

4 CLINICAL TRIALS

"The cross-border IRB and CDSCO/FDA clearance desk allowed our academic spinout to launch dual trials in Boston and Hyderabad simultaneously."

Prof. Sunita Reddy

Prof. Sunita Reddy

Head of Bio-Design · IIT BioLab

DUAL IRB CLEARANCE

"IGVP provides our faculty founders with direct capital market access and venture partner mentorship, increasing spinout survival rates."

Clara Vance

Clara Vance

Tech Transfer Officer · Johns Hopkins TTO

92% SPINOUT SURVIVAL

"IGVP's institutional desk streamlined our tech-transfer licensing process. 3 of our university patents spun out into funded startups this year."

Dr. Arthur Pendelton

Dr. Arthur Pendelton

VP Research · Stanford Health Innovation

3 PATENTS LICENSED

"Our health system onboarded 4 clinical trial cohorts through IGVP's pre-diligenced founder channel with IRB approvals completed in under 30 days."

Dr. Jonathan Roy

Dr. Jonathan Roy

Director of Clinical Trials · Mass General

4 CLINICAL TRIALS

"The cross-border IRB and CDSCO/FDA clearance desk allowed our academic spinout to launch dual trials in Boston and Hyderabad simultaneously."

Prof. Sunita Reddy

Prof. Sunita Reddy

Head of Bio-Design · IIT BioLab

DUAL IRB CLEARANCE

"IGVP provides our faculty founders with direct capital market access and venture partner mentorship, increasing spinout survival rates."

Clara Vance

Clara Vance

Tech Transfer Officer · Johns Hopkins TTO

92% SPINOUT SURVIVAL